The University of Southampton
University of Southampton Institutional Repository

Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations

Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations
Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations

Proliferating cell nuclear antigen (PCNA) is a key cell cycle regulatory protein of known structure and function that also has an important role in DNA repair. Its use as a marker of proliferation can be assessed directly using a thymidine analogue in suitably labelled pathological material. Following optimisation studies, a quantitative and cell cycle phase—specific analysis of PCNA expression in fresh biopsies from 50 colorectal tumours (Series A) was undertaken using dual parameter flow cytometry (FCM). For comparison, quantitative histometric studies of PCNA expression were undertaken on 50 archival bromodeoxyuridine (BrdUrd) labelled colorectal tumours (Series B). In FCM assays, PCNA‐specific fluorescence was displayed throughout the cell cycle in both cells and nuclei under all preparation conditions, but to a very variable extent. The mean PCNA labelling index ranged from 38.7% to 53.0% according to the method of cell extraction used. In the 27 diploid tumours in Series A, the median PCNA LI in G0/G1 was 71.5% (range 27.0–90.6%), in S it was 10.5% (3.3–29.5%), and in G2/M it was 17.4% (5.7–43.5%). In the histometric studies of Series B tumours, the mean [S.D.] PCNA labelling index (LI) was 38.8 [9.8]%, compared with the BrdUrd (histometric) LI of 21.1 [9.0]%. The BrdUrd LI measured by FCM was 12.4 [6.5]%. PCNA‐PC10 is expressed throughout the cell cycle in human colorectal tumour biopsies, which is in keeping with the range of DNA repair, synthesis, and regulatory functions that it is now recognised to perform throughout the cell cycle. © 1995 Wiley‐Liss, Inc.

Flow cytometry, PCNA, proliferating cell nuclear antigen
0196-4763
190-199
Sawtell, Rachael M.
2fbe2bf0-1313-4bd7-886a-24df4bc5216f
Rew, David A.
36dcc3ad-2379-4b61-a468-5c623d796887
Stradling, Robin N.
7b9def9b-95c6-429e-93a6-1259294d3f75
Wilson, George D.
eb5f854f-2cf6-4f0e-b737-b049c44dd16e
Sawtell, Rachael M.
2fbe2bf0-1313-4bd7-886a-24df4bc5216f
Rew, David A.
36dcc3ad-2379-4b61-a468-5c623d796887
Stradling, Robin N.
7b9def9b-95c6-429e-93a6-1259294d3f75
Wilson, George D.
eb5f854f-2cf6-4f0e-b737-b049c44dd16e

Sawtell, Rachael M., Rew, David A., Stradling, Robin N. and Wilson, George D. (1995) Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations. Cytometry, 22 (3), 190-199. (doi:10.1002/cyto.990220306).

Record type: Article

Abstract

Proliferating cell nuclear antigen (PCNA) is a key cell cycle regulatory protein of known structure and function that also has an important role in DNA repair. Its use as a marker of proliferation can be assessed directly using a thymidine analogue in suitably labelled pathological material. Following optimisation studies, a quantitative and cell cycle phase—specific analysis of PCNA expression in fresh biopsies from 50 colorectal tumours (Series A) was undertaken using dual parameter flow cytometry (FCM). For comparison, quantitative histometric studies of PCNA expression were undertaken on 50 archival bromodeoxyuridine (BrdUrd) labelled colorectal tumours (Series B). In FCM assays, PCNA‐specific fluorescence was displayed throughout the cell cycle in both cells and nuclei under all preparation conditions, but to a very variable extent. The mean PCNA labelling index ranged from 38.7% to 53.0% according to the method of cell extraction used. In the 27 diploid tumours in Series A, the median PCNA LI in G0/G1 was 71.5% (range 27.0–90.6%), in S it was 10.5% (3.3–29.5%), and in G2/M it was 17.4% (5.7–43.5%). In the histometric studies of Series B tumours, the mean [S.D.] PCNA labelling index (LI) was 38.8 [9.8]%, compared with the BrdUrd (histometric) LI of 21.1 [9.0]%. The BrdUrd LI measured by FCM was 12.4 [6.5]%. PCNA‐PC10 is expressed throughout the cell cycle in human colorectal tumour biopsies, which is in keeping with the range of DNA repair, synthesis, and regulatory functions that it is now recognised to perform throughout the cell cycle. © 1995 Wiley‐Liss, Inc.

This record has no associated files available for download.

More information

Published date: 15 September 1995
Additional Information: Copyright: Copyright 2016 Elsevier B.V., All rights reserved.
Keywords: Flow cytometry, PCNA, proliferating cell nuclear antigen

Identifiers

Local EPrints ID: 447893
URI: http://eprints.soton.ac.uk/id/eprint/447893
ISSN: 0196-4763
PURE UUID: 447c4aaa-b668-42dd-b34f-57c2698a3732
ORCID for David A. Rew: ORCID iD orcid.org/0000-0002-4518-2667

Catalogue record

Date deposited: 25 Mar 2021 18:28
Last modified: 17 Mar 2024 03:56

Export record

Altmetrics

Contributors

Author: Rachael M. Sawtell
Author: David A. Rew ORCID iD
Author: Robin N. Stradling
Author: George D. Wilson

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×